Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 10, 2023

SELL
$1.11 - $1.87 $5,198 - $8,757
-4,683 Reduced 6.63%
66,000 $86,000
Q3 2022

Nov 03, 2022

BUY
$1.75 - $3.1 $67,765 - $120,041
38,723 Added 121.16%
70,683 $126,000
Q2 2022

Aug 09, 2022

SELL
$1.83 - $3.45 $16,356 - $30,836
-8,938 Reduced 21.85%
31,960 $73,000
Q1 2022

May 09, 2022

BUY
$2.34 - $4.72 $7,534 - $15,198
3,220 Added 8.55%
40,898 $135,000
Q4 2021

Feb 10, 2022

BUY
$4.38 - $15.67 $32,394 - $115,895
7,396 Added 24.42%
37,678 $171,000
Q3 2021

Nov 09, 2021

BUY
$6.36 - $8.51 $46,415 - $62,105
7,298 Added 31.75%
30,282 $217,000
Q2 2021

Aug 05, 2021

BUY
$5.52 - $15.68 $126,871 - $360,389
22,984 New
22,984 $185,000

Others Institutions Holding OCGN

About Ocugen, Inc.


  • Ticker OCGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 216,566,000
  • Market Cap $158M
  • Description
  • Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...
More about OCGN
Track This Portfolio

Track Teacher Retirement System Of Texas Portfolio

Follow Teacher Retirement System Of Texas and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Teacher Retirement System Of Texas, based on Form 13F filings with the SEC.

News

Stay updated on Teacher Retirement System Of Texas with notifications on news.